NK1 antisense oligonucleotide (Ionis Pharmaceuticals/University of California)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNK1 antisense oligonucleotide (Ionis Pharmaceuticals/University of California)
Drug Alias NameNK-1-ASO
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionNeurokinin 1 receptor antagonists
TargetsNeurokinin 1 receptor
Therapy Area/IndicationsMuscle Hypertonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of CaliforniaIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMuscle Hypertonia

Other Information

ATC CodeN/A
Related LinksN/A